Newly Approved Lipid-Lowering Therapies: The Top 5 Things to Know

Our expert panel discusses advances in dyslipidemia management, including new therapies to help reduce total lipoprotein risk. Credit available for this activity expires: 8/3/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/955661?src=mkm_podcast_addon_955661